A group of colleagues working in the medical publications field just posted a preprint (not peer-reviewed) manuscript on Good Practice for Conference Abstracts and Presentations (GP-CAP). The paper works off of the GPP3 guidelines and ICMJE recommendations for developing and publishing manuscripts and tries to tackle some situations that are unique to conference materials and presentations.
The American Medical Writers Association (AMWA), European Medical Writers Association (EMWA), and International Society for Medical Publication Professionals (ISMPP) today released a Joint Position Statement on the Role of Professional Medical Writers (pdf), which is the first unified position on the role of professional medical writers from three leading professional organizations.
The position statement outlines the responsibilities of professional medical writers as well as the responsibilities of the authors who collaborate with medical writers. In addition, there is a template for how to disclose medical writing support in publications.
Make sure your medical writer is practicing in accordance with the new position statement.
Ah, times have changed. An article in JAMA Internal Medicine reveals the practices that led to the 1967 publication of a 2-part literature review on “Dietary Fats, Carbohydrates and Atherosclerotic Disease.”
In short, the review articles were written with heavy involvement from the Sugar Research Foundation, which has since become the Sugar Association with a mission to “promote the consumption of sugar through sound scientific principles while maintaining an understanding of the benefits that sugar contributes to the quality of wholesome foods and beverages.”
From a the perspective of a medical writer acquainted with publication guidelines, the current article lays out a troubling path to publication for the 2-part review. Continue reading Why publication guidelines were made
Companies that sponsor medical research should pay attention to an updated guideline that was recently released. The document, Good Publication Practice for Communicating Company-Sponsored Medical Research“, more commonly known as GPP3, is the third iteration of the guideline, which goes back to 2003.
The guideline covers all types of documents published in peer-reviewed journals (original research articles, short reports, reviews, letters to the editor) and presentations at scientific congresses and meetings (oral presentations, posters, abstracts).
Continue reading GPP3: New guidelines for publishing company-sponsored medical research